FDA grants MRI conditional label extension for Nalu Medical’s neurostimulation system
The FDA label extension means Nalu’s system is deemed safe to offer patients without compromising future diagnostic imaging ...
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
CHICAGO, IL / ACCESS Newswire / January 22, 2025 / ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, ...